Pankreatan (Pancreas Powder From Porcine)

The powder contains natural pancreatic enzymes—amylase, lipase and proteases—that act in the small intestine. By supplementing the body's own enzymes, it catalyzes the hydrolysis of carbohydrates, lipids and proteins, facilitating their digestion and absorption in individuals whose pancreas cannot produce sufficient enzymes.

The appropriate dose of Pankreatan is individualized by the prescribing clinician based on the patient’s degree of enzyme deficiency, type of meals, and clinical response. Dosage is not standardized and should be determined by a qualified healthcare professional.

Safety data for porcine pancreas powder in pregnancy or lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician after careful assessment.

To request Pankreatan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Pankreatan is a porcine‑derived enzyme powder, whereas many alternatives are enteric‑coated tablets or capsules. The powder can be mixed with food or liquids, offering flexibility for patients with swallowing difficulties. Enzyme composition is similar, but formulation differences may affect onset of action and patient preference.

Pankreatan should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain enzyme activity throughout its shelf life.

The powder is intended for oral use. It can be sprinkled onto soft foods, mixed into liquids, or taken directly as directed by the prescriber. Administration should occur with meals or snacks to ensure the enzymes act on ingested nutrients.

Serious risks include severe allergic reactions such as anaphylaxis, exacerbation of pancreatitis, and rare cases of intestinal obstruction. Patients should be monitored for signs of hypersensitivity, persistent abdominal pain, or unusual gastrointestinal symptoms and seek immediate medical attention if they occur.

Pankreatan is contraindicated in individuals with a known hypersensitivity to porcine proteins or any component of the formulation. Patients with a history of severe allergic reactions to pancreatic enzyme preparations should avoid this product.